When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMPE - Ampio Pharma on go with Ampion study in COVID-19 program
Ampio Pharmaceuticals Inc.
Ampio Pharmaceuticals (NYSEMKT:AMPE)initiates dosing patients in Phase 1 U.S. based clinical trial evaluating a 5-day intravenous Ampion treatment for COVID-19 patients requiring supplemental oxygen.
More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,